The only preclinical imaging platform allowing for fast in vivo screening of SPECT and alpha-emitting isotope radiopharmaceuticals
Now available in High Throughput configuration
The γ-eye™ system is now offered in a High Throughput version, designed to accelerate your research workflow without compromising performance.
- Expanded Field-of-View with 100 mm x 200 mm active area
- Real-time in vivo imaging of up to 4 mice or 1 rat
- All key characteristics of the standard γ-eye™ are fully preserved
- Enhanced performance for faster data acquisition and higher experimental throughput
- Perform more than 110 mouse scans per day, maximizing productivity for time-sensitive or large-cohort studies.
Features
- Small animal, SPECT and alpha-emitting isotope live imaging platform
- Optimised to meet the unique imaging challenges of alpha emitter radiotracers
- Detects and resolves the separation of daughter isotopes post alpha decay
- Real time, whole body imaging since time zero post injection, enables fast screening of radiolabeled compounds
- User interchangeable collimators for optimizing parameters on a wide range of applications
Technical Specifications
- State-of-the-art detector characteristics
- <2mm spatial resolution
- Down to 1 sec frames for whole body scans
- Energy resolution down to 19%
- Detectable energy range 35-500 keV
- Weight less than 50kg
- Dimensions: 43cm (L) x 46cm (W) x 43cm (H)
- Compatible with 3rd party anesthesia and Vital Signs monitoring system
Definition of a user friendly platform
- Straightforward workflow with easy imaging protocol set-up
- Plain to operate by non highly-experienced professionals
- Footprint allowing for simple system installation and transfer
- Ideal for imaging inside a clean room, or next to a cyclotron
- Visual | eyes™ software hub for post processing of imaging data
Applications
SPECT
Lu-177 imaging using the γ-eye™
In vivo imaging of Lu-177 on a model with nanoparticles targeting bones. Image info: 24 h post injection acquisition, 20 min static scan. Total injected dose is 540 μCi / 19.98 MBq.
Applications
Oncology, SPECT
In-111 Dotatate imaging using the γ-eye™
The objective of this study was to assess the efficacy of In-111 Dotatate in targeting tumors, with and without the additional use of tumor protection. The images were acquired 3 hours post-injection, with a 6 min static scan. The total injected dose was 108 µCi /3.99 MBq.
Applications
SPECT
Tc-99m imaging using the γ-eye™
Study conducted on a healthy mouse that was injected intravenously with 500μCi (first image from the left) and 300μCi (two subsequent images). We can observe the kinetics of the compound into the body of the mouse, as well as its accumulation at the liver and kidney.
Applications
Oncology, alpha-emitters, SPECT
Ac-225 imaging using γ-eye™
In vivo imaging of alpha-emitting isotopes made possible, with BIOEMTECH technology. Two illustrative images, from two timepoints: 2h and 24h post injection with a Ac-225 radiopharmaceutical, in an oncology model. Image info: Scan duration 10 min. Dose injected: 3.5 μCi / 0.13 MBq. Images acquired at Radiomedix laboratories.
Looking for more info on the γ-eye™ and its applications?
Download the γ-eye™ Brochure